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Abstract
Background: Combined effects between mitochondrial DNA 5178 (Mt5178) C/A polymorphism and alcohol
consumption on the risk of hypertension or hyperuricemia have been reported. The objective of this study was to
investigate whether Mt5178 C/A polymorphism modulates the effects of alcohol consumption on the risk of
dyslipidemia.
Methods: A total of 394 male subjects were selected from among individuals visiting the hospital for regular
medical check-ups. After Mt5178 C/A genotyping, a cross-sectional study assessing the combined effect of Mt5178
polymorphism and alcohol consumption on the risk of dyslipidemia was conducted.
Results: For men with Mt5178C, alcohol consumption was significantly and negatively associated with the risk of
hyper-low-density lipoprotein (LDL) cholesterolemia (serum LDL cholesterol ≥ 140 mg/dl) (P for trend = 0.015).
After adjustment for age, body mass index (BMI), habitual smoking, coffee consumption and use of
antihypertensive medicine, the odds ratio (OR) for hyper-LDL cholesterolemia was significantly lower in daily
drinkers with Mt5178C than non-drinkers with Mt5178C (OR = 0.360, 95% confidence intervals: 0.153-0.847). A
significant and negative association between alcohol consumption and serum LDL cholesterol levels was also
observed in Mt5178C genotypic men (P for trend < 0.01). On the other hand, the association between Mt5178A
genotype and risk of hyper-LDL cholesterolemia does not appear to depend on alcohol consumption.
Conclusions: For Mt5178C genotypic men, alcohol consumption may reduce the risk of hyper-LDL
cholesterolemia.
Introduction
Mitochondrial DNA 5178 (Mt5178) C/A polymorphism,
also known as NADH dehydrogenase subunit-2 237
(ND2-237) Leu/Met, is a longevity-associated mitochon-
drial DNA polymorphism [1-3]. The frequency of the
Mt5178A genotype is significantly higher in Japanese
centenarians than in the general population [1]. Japanese
individuals with Mt5178A are more resistant to lifestyle-
related adult-onset diseases, such as hypertension [4],
diabetes [5], myocardial infarction [6,7] and cerebrovas-
cular disorders [8], than those with Mt5178C. This poly-
morphism is also associated with serum lipid levels [9]
and fasting plasma glucose levels [10].
A combined effect of Mt5178 C/A polymorphism and
alcohol consumption on serum lipid levels has been
reported [11]. Alcohol consumption is negatively asso-
ciated with serum triglyceride levels in healthy male
subjects with Mt5178A and with serum low-density
lipoprotein (LDL) cholesterol levels in those with
Mt5178C [11]. Previous studies have reported the joint
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on the risk of hypertension or hyperuricemia in middle-
aged Japanese men. For men with the Mt5178C geno-
type, daily alcohol consumption may increase the risk of
hypertension [4] or hyperuricemia [12]. However, there
have been no reports on the association between
Mt5178 C/A polymorphism and alcohol intake on the
risk of dyslipidemia, which is clinically important for the
prevention of atherosclerotic diseases [13].
The objective of this study was to investigate whether
there is a joint effect of Mt5178 C/A polymorphism and
alcohol consumption on the risk of dyslipidemia in mid-
dle-aged Japanese male subjects.
Materials and methods
Study subjects
Participants were recruited from among individuals vis-
iting the Mito Red Cross Hospital for regular medical
check-ups between August 1999 and August 2000. This
study was conducted in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee
of the Kyorin University School of Medicine. Written
informed consent was obtained from 602 volunteers
before participation. Because the number of women was
insufficient for classification into groups based on
Mt5178 C/A genotype and alcohol consumption habits,
women were excluded. Patients taking antihyperlipi-
demic medication were excluded, and diabetic patients
were also excluded because of their higher prevalence of
dyslipidemia when compared to non-diabetic patients
[14]. Thus, 406 men, including patients using antihyper-
tensive medication, were enrolled in the study. Twelve
individuals with unclear data were also excluded. There-
fore, subjects comprised 394 Japanese men (age, 53.9 ±
7.9 years; mean ± SD).
Clinical characteristics of subjects
Determination of blood chemical and physical data was
conducted as described previously [9]. Serum total cho-
lesterol levels, serum high-density lipoprotein (HDL)
cholesterol levels, serum triglyceride levels, fasting
plasma glucose levels and serum uric acid levels were
measured using standard laboratory techniques. LDL
cholesterol levels were calculated by Friedewald’sf o r -
mula [15]. Dyslipidemias were defined according to the
Japan Atherosclerosis Society guidelines for the preven-
tion of atherosclerotic cardiovascular diseases (hyper-
LDL cholesterolemia was defined as serum LDL choles-
terol ≥ 140 mg/dl, hypo-HDL cholesterolemia was
defined as serum HDL cholesterol < 40 mg/dl and
hypertriglyceridemia was defined as serum triglyceride ≥
150 mg/dl) [13]. The values presented for both systolic
blood pressure and diastolic blood pressure were the
averages of two measurements obtained by physicians.
Body mass index (BMI) was defined as the ratio of sub-
ject weight (kg) to the square of subject height (m). A
survey of alcohol consumption, habitual smoking, coffee
intake and use of antihypertensive medication was per-
formed by means of questionnaire. Alcohol consump-
tion was classified based on drinking frequency (daily
drinkers; occasional drinkers, which include those who
drink several times per week or per month; and non- or
ex-drinkers). Habitual smoking was classified as non- or
ex-smokers and current smokers. Coffee consumption
was classified based on number of cups of coffee per
day (less than one cup per day; one, two or three cups
per day; and more than four cups per day). For use of
antihypertensive medication, subjects were classified as
taking no drug treatment or taking medicine.
Genotyping
DNA was extracted from white blood cells using the DNA
Extractor WB kit (Wako Pure Chemical Industries, Japan).
The Mt5178 C/A polymorphism was detected by polymer-
ase chain reaction (PCR) and digestion with AluI restric-
tion enzyme. Primers were: forward 5’-CTTAG CAT
ACTCCTCAATTACCC-3’; and reverse 5’-GTGAA
TTCTTCGATAATGGCCCA-3’. PCR was performed
with 50 ng of genomic DNA in buffer containing 0.2
μmol/l each primer, 1.25 mmol/l dNTPs, 1.5 mmol/l
MgCl2, and 1 U of Taq DNA polymerase. After an initial
denaturation at 94°C for 5 min, PCR was conducted
through 40 cycles as follows: denaturation at 94°C for 30 s;
annealing at 60°C for 60 s; and polymerase extension at
72°C for 90 s. After cycling, a final extension at 72°C for
10 min was performed. PCR products were digested with
AluI restriction enzyme (Nippon Gene, Japan) at 37°C
overnight, and were electrophoresed on 1.5% agarose gels
stained with ethidium bromide for visualization under
ultraviolet light. The absence of an AluIs i t ew a sd e s i g -
nated as Mt5178A (279-bp fragment), and the presence of
this restriction site was designated as Mt5178C (175-bp
and 104-bp fragments).
Statistical analyses
Statistical analyses were performed using SAS statistical
software, version 9.1, for Windows (SAS Institute, Inc.,
Cary, NC, 2002). Multiple logistic regression analysis
was used to calculate the odds ratio (OR) of dyslipide-
mia. Differences in serum lipid levels between groups by
alcohol consumption were evaluated using the least
square means calculated from analysis of covariance.
Differences with P values of less than 0.05 were consid-
ered to be statistically significant.
Results
No significant differences in biophysical or biochemical
characteristics, or in frequency of dyslipidemia were
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(Table 1).
Significant and negative associations between alcohol
consumption and the risk of hyper-LDL cholesterol
were observed in Mt5178C genotypic men (P for trend
= 0.015 and adjusted P for trend = 0.014, respectively).
The OR for hyper-LDL cholesterolemia was significantly
lower in daily drinkers with Mt5178C than in non-drin-
kers with Mt5178C (OR = 0.408, 95% confidence inter-
vals (CI): 0.188-0.888, P = 0.024) (Table 2). After
adjustment for age, body mass index, habitual smoking,
coffee consumption and use of antihypertensive medica-
tion, a significant OR remained (OR = 0.360, 95% CI:
0.153-0.847, P = 0.019). On the other hand, the associa-
tion between Mt5178A genotype and hyper-LDL choles-
terolemia does not appear to depend on alcohol
consumption. No significant joint effect of Mt5178 C/A
polymorphism and alcohol consumption on risk of
hypo-HDL cholesterolemia or hypertrygliceridemia was
observed (data not shown).
Bonferroni correction for multiple comparisons
revealed that serum LDL levels were significantly lower
in daily drinkers with Mt5178C than in non- or ex-drin-
kers with Mt5178C (P = 0.011) (Table 3). After adjust-
ing for age and BMI, serum LDL cholesterol levels were
also significantly lower in daily drinkers with Mt5178C
than in non- or ex-drinkers with Mt5178C (P = 0.007).
Moreover, after adjusting for age, BMI, habitual smok-
ing, coffee consumption and use of antihypertensive
medicine, serum LDL cholesterol levels were signifi-
cantly lower in occasional drinkers with Mt5178C or
daily drinkers with Mt5178C than in non- or ex-drin-
kers with Mt5178C (P =0 . 0 4 9a n dP = 0.008, respec-
tively). As crude and adjusted P-values for trends
reached statistically significant levels (P for trend <
0.01), a significant and negative association between
alcohol consumption and serum LDL cholesterol levels
was confirmed in subjects with Mt5178C genotype. On
the other hand, no noticeable relationship between alco-
hol intake and serum LDL cholesterol levels was
observed in those with the Mt5178A genotype.
Discussion
The present study confirmed a novel gene-environment
interaction. Longevity-associated Mt5178 C/A poly-
morphism and alcohol consumption may combine to
modify the risk of hyper-LDL cholesterolemia in mid-
dle-aged Japanese men. For men with Mt5178C, habi-
tual alcohol consumption may reduce serum LDL
cholesterol levels or risk of hyper-LDL cholesterolemia.
However, for those with Mt5178A, alcohol consumption
does not appear to influence the risk of hyper-LDL
cholesterolemia.
Although our previous analysis was carried out from
the viewpoint of gerontology [11], this analysis of gene-
environment interactions was undertaken to evaluate
the risk of dyslipidemia, which is clinically and preven-
tively important. Therefore, the effect of alcohol on
Table 1 Clinical characteristics of study subjects by Mt5178 C/A genotype
Mt5178C Mt5178A P value
N = 239 N = 155
Age (y) 54.3 ± 7.8 53.2 ± 7.8 0.171
Body Mass Index (kg/m
2) 23.3 ± 2.8 23.5 ± 2.6 0.461
Systolic blood pressure (mmHg) 125.8 ± 15.9 125.7 ± 14.1 0.940
Diastolic blood pressure (mmHg) 74.0 ± 10.7 73.8 ± 9.1 0.829
Total cholesterol (mg/dl) 203.5 ± 34.3 201.9 ± 31.8 0.672
LDL cholesterol (mg/dl) 121.6 ± 34.8 117.9 ± 30.5 0.281
HDL cholesterol (mg/dl) 54.6 ± 13.6 56.3 ± 16.2 0.269
Triglyceride (mg/dl) 136.7 ± 91.1 139.5 ± 90.8 0.766
Fasting plasma glucose (mg/dl) 97.2 ± 9.4 97.6 ± 9.7 0.672
Uric acid (mg/dl) 5.98 ± 1.21 5.92 ± 1.21 0.673
Alcohol consumption (daily/occasional/non- or ex-) (%) 46.4/35.2/18.4 47.7/38.7/13.6 0.426
Coffee consumption (< 1 cup per day/1-3 cups per day/≥ 4 cups per day) (%) 44.8/46.0/9.2 36.8/51.6/11.6 0.274
Current smokers (%) 41.4 40.7 0.878
Antihypertensive medication use (%) 18.8 12.9 0.122
Hyper-LDL cholesterolemia (%) 26.4 25.8 0.903
Hypo-HDL cholesterolemia (%) 11.7 12.3 0.871
Hypertriglyceridemia (%) 29.7 29.7 0.995
LDL; low-density lipoprotein, HDL; high-density lipoprotein. Age, body mass index, systolic blood pressure, diastolic blood pressure, serum total cholesterol levels,
serum LDL cholesterol levels, serum HDL cholesterol levels, serum triglyceride levels, fasting plasma glucose levels and serum uric acid levels are given as means
± S.D. All P values depict significance of differences between Mt5178C and Mt5178A. For alcohol consumption, coffee consumption, current smokers,
antihypertensive medication use, hyper-LDL cholesterolemia, hypo-HDL cholesterolemia and hypertriglyceridemia, P values were calculated by chi-squared test.
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Mt5178C genotypic men may be more clinically and
preventively informative. A previous study reported a
significantly negative correlation between alcohol
intake and serum LDL cholesterol levels among 193
healthy subjects with Mt5178C [11]. In the present
study, among the subjects including patients using
antihypertensive medication, alcohol consumption was
also significantly and negatively associated with serum
LDL cholesterol levels in 239 Mt5178C genotypic men.
On multiple logistic regression analysis or analysis of
covariance, use of antihypertensive medication was
adjusted for.
Individuals with Mt5178C are reported to be more
susceptible to atherosclerotic diseases than those with
Mt5178A [6-8]. Our results suggest that, for Mt5178C
genotypic men, alcohol intake decreases serum LDL
cholesterol levels and reduces the risk of hyper-LDL
cholesterolemia, which is a crucial risk factor for coron-
ary heart disease [13]. However, for men with Mt5178C,
daily alcohol consumption increases the risk of hyper-
tension [4] and hyperuricemia [12]. From the viewpoint
of preventing atherosclerotic diseases, it is difficult to
determine whether alcohol intake is beneficial for
Mt5178C genotypic men. In contrast, individuals with
Mt5178A are genetically more resistant to atherosclero-
tic diseases than those with Mt5178C. For men with
Mt5178A, alcohol intake decreases serum triglyceride
levels [11]. However, daily alcohol consumption is posi-
tively associated with yearly changes in serum LDL cho-
lesterol levels in men with Mt5178A [16]. It is also
unclear whether alcohol consumption is favorable for
Mt5178A genotypic men.
Combined effects of Mt5178 C/A polymorphism and
coffee consumption on risk factors for atherosclerotic
diseases have been reported previously [17,18]. For men
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for hyper-LDL cholesterolemia by Mt5178 C/A genotype
and alcohol consumption
Frequency
Genotype and alcohol consumption Normal LDL cholesterol
(LDL cholesterol < 140 mg/dl)
Hyper-LDL cholesterolemia
(LDL cholesterol ≥ 140 mg/dl)
OR (95% CI) Adjusted OR†
(95% CI)
Mt5178C
Non- or ex-drinkers (%) 28 (63.6) 16 (36.4) 1 (reference) 1 (reference)
Occasional drinkers (%) 58 (69.1) 26 (30.9) 0.784 (0.364-1.692) 0.694 (0.290-1.660)
Daily drinkers (%) 90 (81.1) 21 (18.9) 0.408 (0.188-0.888)* 0.360 (0.153-0.847)*
P for trend = 0.015 P for trend = 0.014
Mt5178A
Non- or ex-drinkers (%) 16 (76.2) 5 (23.8) 1 (reference) 1 (reference)
Occasional drinkers (%) 45 (75.0) 15 (25.0) 1.067 (0.334-3.409) 1.190 (0.318-4.447)
Daily drinkers (%) 54 (73.0) 20 (27.0) 1.185 (0.384-3.660) 1.232 (0.361-4.206)
P for trend = 0.730 P for trend = 0.558
LDL; low-density lipoprotein. †OR adjusted for age, body mass index, habitual smoking, coffee consumption and antihypertensive medication use.
*P < 0.05.
Table 3 Serum LDL cholesterol levels in habitual alcohol consumption groups by Mt5178 C/A genotype
Alcohol consumption P for trend
Non- or ex-drinkers Occasional drinkers Daily drinkers
Mt5178C N = 44 N = 84 N = 111
LDL cholesterol 135.0 ± 5.2 120.5 ± 3.7 117.1 ± 3.3* 0.007
LDL cholesterol † 135.8 ± 5.2 120.4 ± 3.8 116.9 ± 3.3** 0.005
LDL cholesterol ‡ 135.6 ± 6.3 119.5 ± 4.9* 116.4 ± 4.1** 0.006
Mt5178A N = 21 N = 60 N = 74
LDL cholesterol 121.4 ± 6.7 118.5 ± 4.0 116.5 ± 3.6 0.506
LDL cholesterol † 122.1 ± 6.7 118.4 ± 3.9 116.3 ± 3.5 0.445
LDL cholesterol ‡ 121.4 ± 7.5 117.6 ± 5.1 116.1 ± 4.7 0.502
LDL: low-density lipoprotein. †LDL cholesterol levels are given as least-square means ± S.E. adjusted for age and body mass index; ‡LDL cholesterol levels are
given as least-square means ± S.E. adjusted for age, body mass index, habitual smoking, coffee consumption and antihypertensive medication use. Bonferroni
correction for multiple comparisons was applied. *P < 0.05 vs. Non- or ex-drinkers with Mt5178C; **P < 0.01 vs. Non- or ex-drinkers with Mt5178C.
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the risk of hypertension [17] and abnormal glucose tol-
erance [18], and may thus reduce the risk of athero-
sclerotic diseases. Whereas coffee intake appears to
provide antiatherogenic benefits for Mt5178C genotypic
men, for Mt5178A genotypic men, coffee consumption
appears to increase the risk of hyper-LDL cholesterole-
mia [19]. Using genotyping of Mt5178 C/A, integration
of information regarding alcohol or coffee consumption
may contribute to personalized prevention of life-threa-
tening cardiovascular or cerebrovascular diseases.
Although the association between increasing alcohol
intake and decreasing serum LDL cholesterol levels is
not apparently modified by alcohol dehydrogenase geno-
type [20], Corella et al. reported that, among men with
apolipoprotein E gene (APOE) ε2,s e r u mL D Lc h o l e s -
terol levels were significantly lower in drinkers than in
non-drinkers [21]. In addition to APOE ε2/ε3/ε4 allele
types, several polymorphisms, such as apolipoprotein A5
gene polymorphism [22], apolipoprotein C-III gene poly-
morphism [23], peroxisome proliferator-activated recep-
tor a gene polymorphism [24], cholesteryl ester transfer
protein Taq1B polymorphism [25] and promoter poly-
morphism of hepatic lipase gene [26], influence the
effects of alcohol consumption on serum LDL choles-
terol concentrations. Therefore, gene-gene-environment
or gene-gene-gene-environment interactions with serum
LDL cholesterol levels should be investigated. Further
genetic epidemiological investigations will establish indi-
vidualized alcohol drinking habits in terms of optimizing
serum LDL cholesterol concentrations.
The mechanisms underlying the joint effects of
Mt5178 C/A (ND2-237 Leu/Met) polymorphism and
alcohol consumption on the risk of hyper-LDL choles-
t e r o l e m i ar e m a i nu n k n o w n .T h e yp r e s u m a b l yd e p e n d
on the amino-acid-related biochemical differences in
NADH dehydrogenase in response to alcohol between
ND2-237Leu and ND2-237Met. In any case, clarification
of the mechanisms of the combined effects of Mt5178
C/A (ND2-237 Leu/Met) polymorphism and alcohol
consumption on serum LDL cholesterol concentrations
remains a matter for further molecular biological
investigation.
Chi-squared test did not reveal a significant difference
in the frequency of Mt5178A between this study and
other molecular epidemiological studies [27], thus sug-
gesting that there is no genetic bias in the subjects in
this study. However, there may have been selection bias
due to the recruiting of subjects from among those visit-
ing the hospital for regular medical check-ups. More-
over, the sample size was not sufficient to test the
research hypothesis. Although cross-sectional studies
can provide a suggestive causality, they cannot establish
solid causal links. Therefore, in order to resolve these
problems, a large-scale population-based follow-up
study is necessary.
Another limitation of this study was the evaluation of
habitual alcohol intake based on the frequency of alco-
hol consumption. As there is a J-shaped curve for the
relationship between volume of alcohol consumption
and risk of coronary heart disease [28] or ischemic
stroke [29], evaluation of volume of alcohol consump-
tion is of great import. Although we have also used this
evaluation in previous studies [4,11,12,16,30], whether
there is any joint effect between Mt5178 C/A poly-
morphism and volume of alcohol intake on the risk of
hyper-LDL cholesterolemia warrants further investiga-
tion. Männistö et al. reported that the percentage of
energy from fat was significantly lower in male abstai-
ners than in male alcohol drinkers [31]. Therefore, diet-
ary information is required in order to precisely evaluate
the relationship between alcohol consumption and
serum LDL cholesterol concentration. In this study,
LDL cholesterol levels were calculated by means of Frie-
dewald’s formula [15]. Therefore, direct measurement of
serum LDL cholesterol levels is desirable.
In conclusion, a joint effect of longevity-associated
Mt5178 C/A polymorphism and habitual alcohol con-
sumption on the risk of hyper-LDL cholesterolemia was
observed in middle-aged Japanese men. For men with
Mt5178C, alcohol intake may reduce the risk of hyper-
LDL cholesterolemia. Considering that daily alcohol
consumption increases other risk factors of atherosclero-
tic diseases for Mt5178C genotypic men [4,12], it is dif-
ficult to determine whether habitual drinking is
preventively beneficial. Although further investigation
will be required to establish the individualized optimum
for maximizing the risk reduction and minimizing the
risk increase of habitual alcohol drinking for athero-
sclerotic diseases, this information regarding the Mt5178
C/A polymorphism will probably contribute to persona-
lized prevention for cardiovascular or cerebrovascular
events.
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